Neuroprotective effect of granulocyte colony-stimulating factor after focal cerebral ischemia

Background and Purpose: The potential neuroprotective effect of the granulocyte colony-stimulating factor (G-CSF) after glutamate-induced excitotoxicity in cell culture and after focal cerebral ischemia in rats was studied. We hypothesized the existence of the G-CSF receptor (G-CSFR) as a main G-CSF...

Full description

Saved in:
Bibliographic Details
Main Authors: Schäbitz, Wolf-Rüdiger (Author) , Kollmar, Rainer (Author) , Schwaninger, Markus (Author) , Jüttler, Eric (Author) , Bardutzky, Jürgen (Author) , Schölzke, Marion Nicola (Author) , Sommer, Clemens (Author) , Schwab, Stefan (Author)
Format: Article (Journal)
Language:English
Published: February 13, 2003
In: Stroke
Year: 2003, Volume: 34, Issue: 3, Pages: 745-751
ISSN:1524-4628
DOI:10.1161/01.STR.0000057814.70180.17
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1161/01.STR.0000057814.70180.17
Verlag, lizenzpflichtig, Volltext: https://www.ahajournals.org/doi/10.1161/01.STR.0000057814.70180.17
Get full text
Author Notes:W.-R. Schäbitz, R. Kollmar, M. Schwaninger, E. Juettler, J. Bardutzky, M.N. Schölzke, C. Sommer, S. Schwab
Description
Summary:Background and Purpose: The potential neuroprotective effect of the granulocyte colony-stimulating factor (G-CSF) after glutamate-induced excitotoxicity in cell culture and after focal cerebral ischemia in rats was studied. We hypothesized the existence of the G-CSF receptor (G-CSFR) as a main G-CSF effector on neurons, and immunohistochemistry, immunoblotting, and polymerase chain reaction were performed. The G-CSFR-mediated action was studied by activation of signal transducer(s) and activator(s) of transcription-3 (STAT3) in the periphery of the infarction. Methods: Neuroprotection of various G-CSF concentrations on glutamate-induced excitotoxicity was studied in cell culture. In vivo, ischemia was induced by use of a suture occlusion model of the middle cerebral artery (90-minute occlusion) in the rat. Thirty minutes after the induction of ischemia, the animals (n=12 per group) received G-CSF at 60 μg/kg body wt IV for 90 minutes or vehicle (saline). Infarct volume was calculated on the basis of 2,3,5-triphenyltetrazolium chloride staining 24 hours after ischemia. Expression of the G-CSFR was studied by immunohistochemistry and verified by reverse transcription-polymerase chain reaction and immunoblotting. Expression of STAT3 was determined by immunohistochemistry. Results: In cell culture, G-CSF exhibited a significant neuroprotective effect after glutamate-induced excitotoxicity (P<0.05). A G-CSF concentration of 10 ng/mL was maximally effective, resulting in a nearly complete protection. In vivo, G-CSF reduced infarct volume to 47% (132.0±112.7 mm3 versus 278.9±91.6 mm3 [P<0.05] in the control group). Immunohistochemistry, Western blotting, and reverse transcription-polymerase chain reaction revealed the existence of G-CSFRs in neurons and glial cells. Animals treated with G-CSF significantly upregulated STAT3 in the periphery of the infarction compared with control animals (P<0.05). Conclusions: G-CSF achieved a significant neuroprotective effect in cell culture and after intravenous administration after stroke. Increased STAT3 expression in the penumbra of G-CSF-treated rats suggests mediation by G-CSFR.
Item Description:Gesehen am 29.03.2021
Physical Description:Online Resource
ISSN:1524-4628
DOI:10.1161/01.STR.0000057814.70180.17